In conclusion, comprehensive metabolic phenotyping of mice harboring the Crebrf R458Q variant revealed only limited effects of the mutation, which did not reproduce either the increased obesity or decreased diabetes risk reported in human variant carriers. This evidence concerns the gene CREBRF and obesity due to melanocortin 4 receptor deficiency.